Thyroid 2021 Aug 3. Epub 2021 Aug 3.
University of Pittsburgh, Surgery, Division of Endocrine Surgery, 101 Kaufmann, 3471 Fifth Avenue, Pittsburgh, United States, 15213.
: Molecular testing (MT) is commonly used to refine cancer probability in thyroid nodules with indeterminate cytology. Whether or not ultrasound (US) patterns and clinical parameters can further inform the risk of thyroid cancer in nodules predicted to be positive or negative by MT remains unknown. Aim: To test if clinical parameters, including patient age, gender, nodule size (by US), Bethesda category (III, IV, V), US pattern (American Thyroid Association [ATA] vs American College of Radiology TI-RADS systems), radiation exposure, or family history of thyroid cancer can modify the probability of thyroid cancer or NIFTP predicted by MT. Read More